Treatment of hereditary angioedema with plasma-derived C1 inhibitor
Michael J Prematta, Tracy Prematta, Timothy J CraigSection of Allergy and Immunology, Penn State University, Milton S. Hershey Medical Center, PA, USABackground: Plasma-derived C1 inhibitor (C1-INH) concentrate is a treatment option for acute hereditary angioedema (HAE) attacks and is considered the...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2008-08-01
|
Series: | Therapeutics and Clinical Risk Management |
Online Access: | http://www.dovepress.com/treatment-of-hereditary-angioedema-with-plasma-derived-c1-inhibitor-a2002 |